These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 7944418)
1. [Pharmacokinetic studies on continuous intraportal 5-fluorouracil infusion]. Matsuzaki H; Yamamura T; Hanai A; Oikawa H; Kikuchi K; Seo K; Ozasa T; Akaishi O; Tsukikawa S; Yamaguchi S Gan To Kagaku Ryoho; 1994 Sep; 21(13):2121-3. PubMed ID: 7944418 [TBL] [Abstract][Full Text] [Related]
2. [Pharmacokinetic studies of continuous and bolus intraportal 5-fluorouracil infusion]. Hanai A; Yamamura T; Matsuzaki H; Oikawa H; Kikuchi K; Ozasa T; Akaishi O; Senda T; Katayama K Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1536-9. PubMed ID: 1530302 [TBL] [Abstract][Full Text] [Related]
3. [Distribution of 5-FU in rat plasma and liver tissue after local 5-FU infusion]. Zheng JL; Liang LJ; Hu WJ; Shen SL Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):823-7. PubMed ID: 18504211 [TBL] [Abstract][Full Text] [Related]
4. [Pharmacokinetic study of postoperative peritoneal infusion with large bulk heated hypotonic 5-fluorouracil fluid for prevention of recurrence and hepatic metastasis of gastric cancer]. Lin AD; Sun HY; Qu MW; Wang FJ; Wang JY; Li ZJ Ai Zheng; 2002 Apr; 21(4):424-9. PubMed ID: 12452026 [TBL] [Abstract][Full Text] [Related]
5. [An experimental study on portal infusion of 5-fluorouracil (the second report)]. Ishida H; Iwama T; Ide A; Nihei Z; Imajo M; Mishima Y Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1532-5. PubMed ID: 1530301 [TBL] [Abstract][Full Text] [Related]
6. [In vivo comparative study of the pharmacokinetics of chemotherapeutic agents infused via hepatic artery or portal vein against hepatic metastases. DRC Group]. Naomoto Y; Gochi A; Hizuta A; Iwagaki H; Matsuno T; Hamazaki K; Tanaka N; Orita K Gan To Kagaku Ryoho; 1993 Aug; 20(11):1555-8. PubMed ID: 8373217 [TBL] [Abstract][Full Text] [Related]
7. Tissue levels of chemotherapeutic agents for hepatic metastasis during hepatic arterial and portal injection. Kaneko A; Naomoto Y; Aoyama M; Tanaka N In Vivo; 1999; 13(2):195-8. PubMed ID: 10363178 [TBL] [Abstract][Full Text] [Related]
8. [Superior mesenteric arterial infusion chemotherapy in patient with both peritoneal carcinomatosis and liver metastasis]. Ueshima Y; Taniguchi H; Miyata K; Suganuma Y; Takeuchi K; Oguro A; Tsukuda N; Takahashi T Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1731-3. PubMed ID: 1530343 [TBL] [Abstract][Full Text] [Related]
9. [An experimental study on portal infusion of 5-fluorouracil]. Ishida H; Iwama T; Nishioka Y; Endo S; Okubo Y; Imajo M; Otomo M; Mishima Y Gan To Kagaku Ryoho; 1991 Aug; 18(11):1884-8. PubMed ID: 1877831 [TBL] [Abstract][Full Text] [Related]
10. [Experimental study on adequate 5-FU dose and flow volume for continuous arterial liver infusion]. Mori T; Iwasaki Y; Takahashi K; Takahashi T Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1547-9. PubMed ID: 1530305 [TBL] [Abstract][Full Text] [Related]
11. Studies on the first-pass metabolism of ebastine in rats. Fujii T; Matsumoto S; Hatoyama T; Miyazaki H Arzneimittelforschung; 1997 Aug; 47(8):949-53. PubMed ID: 9296281 [TBL] [Abstract][Full Text] [Related]
12. Establishment of an experimental model for continuous intraportal infusion of chemo/immunotherapeutic agents in the rat. Rafique M; Adachi W; Shiohara E Anticancer Res; 1995; 15(5B):1869-72. PubMed ID: 8572571 [TBL] [Abstract][Full Text] [Related]
13. [Evaluation of 5-fluorouracil concentration in peripheral blood and side effects in continuous hepatic arterial infusion chemotherapy for patients with unresectable liver cancer]. Fujii K; Nakashima K; Ohno T; Anai H Gan To Kagaku Ryoho; 1997 Sep; 24(12):1835-7. PubMed ID: 9382545 [TBL] [Abstract][Full Text] [Related]
14. [Pharmacokinetic comparison of intraperitoneal and intravenous 5-Fu administration]. Qing SH Zhonghua Zhong Liu Za Zhi; 1991 Sep; 13(5):340-2. PubMed ID: 1782844 [TBL] [Abstract][Full Text] [Related]
15. [Dose, administration time and route and hepatic function-dependent metabolism of 5-FU in mice]. Okamoto M; Takao A; Fujita H Gan To Kagaku Ryoho; 1986 Dec; 13(12):3483-90. PubMed ID: 3789759 [TBL] [Abstract][Full Text] [Related]
16. Superiority of hepatic arterial infusion in preventing catabolism of 5-FU compared with portal vein infusion revealed by an in vivo 19F NMR study. Okuno K; Hirai N; Lee YS; Tarabar D; Ueno H; Yasutomi M Cancer Chemother Pharmacol; 1998; 42(4):341-4. PubMed ID: 9744781 [TBL] [Abstract][Full Text] [Related]
17. [The effect of intraportal chemotherapy in terms of administered dose of 5-FU]. Yamamura T; Matsuzaki H; Tsukikawa S; Akaishi O; Ozasa T; Miyake H; Tanaka K; Seo K; Oikawa H; Hanai A; Kikuchi K; Yamaguchi S Gan To Kagaku Ryoho; 1996 Sep; 23(11):1461-3. PubMed ID: 8854780 [TBL] [Abstract][Full Text] [Related]
18. [Final results of a randomized clinical trial of adjuvant intraportal chemotherapy for colorectal cancer: Intraportal Chemotherapy for Colorectal Cancer Group]. Yamamura T; Yabe K; Oka H; Kouzuma T; Kawahara H; Wakayama T; Sugiura A; Hagiwara M; Ohdate K; Miyajima N; Maeda C; Okamura R; Miyahara T; Moriyama Y; Yamaguchi S; Gunji A; Gan To Kagaku Ryoho; 2002 Oct; 29(10):1765-71. PubMed ID: 12402427 [TBL] [Abstract][Full Text] [Related]
19. Regional pharmacokinetics of 5-bromo-2'-deoxyuridine and 5-fluorouracil in dogs: hepatic arterial versus portal venous infusions. Kuan HY; Smith DE; Ensmiger WD; Knol JA; DeRemer SJ; Yang Z; Stetson PL Cancer Res; 1996 Oct; 56(20):4724-7. PubMed ID: 8840990 [TBL] [Abstract][Full Text] [Related]
20. Comparison of 5-fluorouracil pharmacokinetics in whole blood, plasma, and red blood cells in patients with colorectal cancer. Wattanatorn W; McLeod HL; Macklon F; Reid M; Kendle KE; Cassidy J Pharmacotherapy; 1997; 17(5):881-6. PubMed ID: 9324177 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]